Mason Financial Acquires DiagCor Technology
Dechert advised Mason Financial Holdings Limited, a Hong Kong listed company, on its approximately HK$214.2 million acquisition of the entire issued share capital of two target companies, which collectively hold approximately 48.3% of DiagCor Technology Limited, the holding company of a group of leading molecular diagnostics companies in Hong Kong. The transaction closed on January 4, 2017. This transaction allows our client to further capture growth opportunities in the life sciences and premium medical service industry in Hong Kong and creates synergies with its HK$513.9 million acquisition of a group of leading private assisted reproductive service providers in Hong Kong.
The transaction was led by corporate partner, Stephen Chan and assisted by associate Nicole Wong of Dechert’s Hong Kong office.
About Dechert
Dechert is a global specialist law firm with a deep bench of experts focused on sectors with the greatest complexities and highest regulatory demands. We deliver practical commercial insight and judgment to our clients’ most important matters. Nothing stands in the way of giving clients the best of the firm’s entrepreneurial energy and seamless collaboration in a way that is distinctively Dechert.
